Ligand validation:4RX4

NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose

NAG is a Ligand Of Interest in 4RX4 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4RX4_NAG_G_501	42%	54%	0.199	0.92	0.81	0.98	1	1	0	0	100%	0.9333
4RX4_NAG_G_503	26%	73%	0.293	0.936	0.32	0.71	-	1	0	0	100%	0.9333
4RX4_NAG_G_504	22%	61%	0.331	0.949	0.66	0.82	1	1	1	0	100%	0.9333
4RX4_NAG_E_504	9%	81%	0.268	0.767	0.23	0.59	-	1	2	0	93%	0.9333
4RX4_NAG_E_502	5%	80%	0.415	0.835	0.34	0.5	-	-	1	0	100%	0.9333
4RX4_NAG_E_503	4%	79%	0.41	0.794	0.44	0.43	-	-	1	0	100%	0.9333
4RX4_NAG_G_505	3%	80%	0.409	0.757	0.42	0.43	-	-	0	0	100%	0.9333
4RX4_NAG_E_505	3%	76%	0.363	0.72	0.3	0.65	-	1	0	0	93%	0.9333
4RX4_NAG_G_502	3%	73%	0.329	0.677	0.43	0.61	-	-	1	0	93%	0.9333
4RX4_NAG_E_501	2%	62%	0.437	0.745	0.51	0.95	-	1	1	0	100%	0.9333
4RX4_NAG_G_506	1%	76%	0.307	0.511	0.41	0.54	-	-	0	0	100%	0.9333
4XMP_NAG_G_509	94%	76%	0.066	0.964	0.45	0.5	-	-	0	0	100%	0.9333
4XNY_NAG_G_508	74%	88%	0.13	0.96	0.22	0.44	-	-	0	0	100%	0.9333
3H0C_NAG_A_794	100%	56%	0.021	0.995	0.61	1.08	-	1	0	0	100%	0.9333
5F9W_NAG_A_510	100%	88%	0.023	0.994	0.24	0.43	-	-	0	0	100%	0.9333
5LDS_NAG_B_1007	100%	67%	0.022	0.995	0.48	0.79	-	-	0	0	100%	0.9333
5O5D_NAG_A_601	100%	65%	0.022	0.994	0.32	0.99	-	1	0	0	100%	0.9333
6MUG_NAG_G_629	100%	76%	0.022	0.994	0.35	0.58	-	-	0	0	100%	0.9333

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.